Skip to main content

Animations

MJFF Publications

5261 - 5270 of 8444 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12033
    Citation Count: 119
  • Summary Details
    RESTRICTED
    Title: Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale
    Journal Name: Neuroepidemiology
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1159/000507827
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Клеточная заместительная терапия при болезни Паркинсона – история развития и перспективы использования в клинической практике
    Journal Name: Молекулярная биология
    Publisher: The Russian Academy of Sciences
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.31857/s0026898420060063
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Clinical Trial Highlights – Infusion Therapies
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-199005
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Participation and consultation engagement strategies have complementary roles: A case study of patient and public involvement in clinical practice guideline development
    Journal Name: Health Expectations
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/hex.13018
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Unique white matter structural connectivity in early-stage drug-naive Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000008867
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors
    Journal Name: Biochemical Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bcp.2019.113788
    Best OA location URL:
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: The Effects of Music-Contingent Gait Training on Cognition and Mood in Parkinson Disease: A Feasibility Study
    Journal Name: Neurorehabilitation and Neural Repair
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/1545968319893303
    Best OA location URL:
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2019.100804
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Deubiquitinase USP29 Governs MYBBP1A in the Brains of Parkinson’s Disease Patients
    Journal Name: Journal of Clinical Medicine
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/jcm9010052
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.